• Novartis and Oxford University begin R&D tie-up pharmaphorum
    January 21, 2019
    Novartis and Oxford University have begun a partnership that will attempt to use artificial intelligence to predict how patients will respond to new and existing treatments for inflammatory diseases such as multiple sclerosis (MS) and psoriasis.
PharmaSources Customer Service